Michael Phelan and Jonathan Petty | Virginia Trial Attorneys

Low-T (Testosterone) Drugs

Testosterone treatments have been used legitimately for a long time to treat men with a reduced ability to produce testosterone because of such causes as trauma, chemotherapy, genetic abnormalities, or undescended testicles. The deceptive advertisements for these “Low-T” drugs feature attractive, fit men who would not be in such great shape if they actually had low energy. Much like during the erectile dysfunction pill phenomenon, the drug manufacturers have figured out that human beings are afraid of aging, and have done a good job convincing men that Low-T is a common disease, which should be treated with their drugs.

Low-T drugs can be dangerous. Testosterone replacement therapies do not simply boost a man’s testosterone, but, according to studies published in peer reviewed medical journals, they may also increase the risk of heart attack, stroke, and death. Men older than 65 years of age and younger men with other risks for heart disease were found to have a two-fold risk of non-fatal heart attack shortly after starting testosterone replacement therapy. Moreover, once a man takes testosterone replacement therapy for a certain period, his body loses the ability to make testosterone on its own.

Men older than 65 with a history of heart disease were found to be 30% more likely to suffer a heart attack, stroke, or death.

Testosterone gels, which are applied under the armpit like a deodorant, represent nearly 90% of the $5 billion estosterone replacement therapy market. Here is a list of gels being marketed to treat Low T:

  • AndroGel (currently 66% of prescriptions in the gel market)
  • Androderm
  • Axiron
  • Bio-T-Gel
  • Delatestryl
  • Depo-Testosterone
  • Fortesta
  • Striant
  • Testim
  • Testopel

The first lawsuits in this litigation have already been filed. Please contact us if you or a loved one has been injured or killed from taking a testosterone replacement drug.

Related blogs: